1992
DOI: 10.1002/1097-0142(19920901)70:5<1111::aid-cncr2820700515>3.0.co;2-4
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasonography and ultrasonographically guided fine-needle aspiration biopsy of impalpable cervical lymph nodes in patients with non-small cell lung cancer

Abstract: Background. Neck ultrasonography (US) and ultrasonographically guided fine‐needle aspiration (UGFNA) cytologic examination were used in the staging work‐up of 51 consecutive patients with non‐small cell lung cancer (NSCLC) with clinically impalpable cervical lymphadenopathy. Methods. All patients had chest radiography, fiberoptic bronchoscopic examination, computed tomography (CT) scans of the chest and abdomen, bone scan, and US of the abdomen and the neck. Results. Six patients (12%) were found to have cervi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
3
0

Year Published

1996
1996
2011
2011

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(6 citation statements)
references
References 19 publications
3
3
0
Order By: Relevance
“…In other malignant diseases, such as melanoma [4], esophageal cancer [5], and head and neck cancer [6], sonography and sonographically guided fine-needle aspiration cytologic analysis have proved superior to palpation in the detection and characterization of metastasis in supraclavicular lymph nodes. Twelve percent to 31% of patients presenting with lung cancer and a supraclavicular lymph node with a shortaxis diameter of 5 mm or greater have nonpalpable supraclavicular lymph node metastasis at sonographically guided fine-needle aspiration biopsy [9,13]. In our series, a similar percentage (34%) of nonpalpable supraclavicular nodal metastatic lesions was found.…”
Section: Discussionsupporting
confidence: 71%
See 1 more Smart Citation
“…In other malignant diseases, such as melanoma [4], esophageal cancer [5], and head and neck cancer [6], sonography and sonographically guided fine-needle aspiration cytologic analysis have proved superior to palpation in the detection and characterization of metastasis in supraclavicular lymph nodes. Twelve percent to 31% of patients presenting with lung cancer and a supraclavicular lymph node with a shortaxis diameter of 5 mm or greater have nonpalpable supraclavicular lymph node metastasis at sonographically guided fine-needle aspiration biopsy [9,13]. In our series, a similar percentage (34%) of nonpalpable supraclavicular nodal metastatic lesions was found.…”
Section: Discussionsupporting
confidence: 71%
“…Several CT and sonographic methods of assessment of nonpalpable supraclavicular lymphadenopathy have been attempted [7,[9][10][11][12][13][14][15]. PET with 18 F-FDG has been reported to improve the detection of lymph node metastasis and may be more sensitive than other methods because alterations in tissue metabolism generally precede anatomic changes [16].…”
mentioning
confidence: 99%
“…Chang et al determined the prevalence of SC lymph node metastasis as 12% in 51 patients and the majority of the cases had centrally located tumors [15]. In the current study, 68.5% of the cases had centrally located tumor, and the frequency of supraclavicular lymph node involvement was higher in those cases (p < 0.05).…”
Section: Discussionsupporting
confidence: 47%
“…Cervical ultrasonography has been shown to be a reliable investigation for detecting metastatic nodes from cancers of the head and neck [100 -102] and may be superior to even CT for detecting cervical nodal spread from lung cancer [103]. This combined cervical ultrasound and FNA approach has detected occult N3 cervical node metastases in 12% to 31% of lung cancer patients [103,104]; however, the criteria used to identify candidates for FNA was size alone on ultrasonography, which, as discussed earlier, is not a reliable indicator for malignant spread to a lymph node.…”
Section: Cervical Lymph Node Stagingmentioning
confidence: 99%